文献速递妇产影像腹部介入MR

深度学习将DWI转为合成增强T1WI用于MR-HIFU治疗子宫肌瘤的疗效可视化

Diffusion-weighted MRI with deep learning for visualizing treatment results of MR-guided HIFU ablation of uterine fibroids.
PubMed 文献 · Eur Radiol · 2022-12-06

本研究回顾性训练和验证深度学习网络,将MR-HIFU治疗子宫肌瘤过程中的DWI转换为合成CE-T1w图像以显示无灌注体积(NPV)。合成与参考CE-T1w的NPV Dice系数为71%(±22%),NPV比率平均差异1.4%(±22%)且无统计学意义(p=0.79),四位放射科医生对技术治疗成功的绝对一致性为83%。

要点

  • 深度学习可由术中DWI生成合成CE-T1w图像,无需钆对比剂即可显示预测的NPV。
  • 合成与参考CE-T1w的NPV比率估计无显著差异(p=0.27),可用于重复无钆监测治疗进展。
  • 放射科医生基于合成与参考CE-T1w判断技术治疗成功的绝对一致性为83%。

关键影像表现/征象

  • 合成CE-T1w图像由深度学习网络从DWI生成,用于显示预测的NPV。
  • 合成与参考CE-T1w上勾画的NPV的Dice系数为71%(±22%)。
  • 合成与参考CE-T1w的NPV比率平均差异为1.4%(±22%),无统计学意义(p=0.79)。
  • 四位放射科医生对合成与参考CE-T1w上技术治疗成功的绝对一致性为83%。
  • 合成与参考CE-T1w的NPV比率估计无显著差异(p=0.27)。

诊断标准与关键数值

  • NPV分割一致性:合成与参考CE-T1w上勾画NPV的Dice系数为71%(±22%)。
  • NPV比率一致性:合成与参考CE-T1w的NPV比率平均差异为1.4%(±22%),p=0.79。
  • 读者评估一致性:四位放射科医生对技术治疗成功的绝对一致性为83%。
  • NPV比率估计比较:合成与参考CE-T1w间无显著差异(p=0.27)。

临床应用与阅片要点

  • 在MR-HIFU治疗子宫肌瘤过程中,可利用术中DWI生成合成CE-T1w图像,无钆显示预测NPV。
  • 合成CE-T1w可用于重复监测治疗进展,避免反复采集CE-T1w扫描的安全顾虑。
  • 放射科医生基于合成CE-T1w判断技术治疗成功与参考CE-T1w的绝对一致性为83%,可作为无对比剂替代方案参考。

局限性

  • 研究为回顾性设计。
  • 训练集33例、验证集20例,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: No method is available to determine the non-perfused volume (NPV) repeatedly during magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU) ablations of uterine fibroids, as repeated acquisition of contrast-enhanced T1-weighted (CE-T1w) scans is inhibited by safety concerns. The objective of this study was to develop and test a deep learning-based method for translation of diffusion-weighted imaging (DWI) into synthetic CE-T1w scans, for monitoring MR-HIFU treatment progression.

METHODS: The algorithm was retrospectively trained and validated on data from 33 and 20 patients respectively who underwent an MR-HIFU treatment of uterine fibroids between June 2017 and January 2019. Postablation synthetic CE-T1w images were generated by a deep learning network trained on paired DWI and reference CE-T1w scans acquired during the treatment procedure. Quantitative analysis included calculation of the Dice coefficient of NPVs delineated on synthetic and reference CE-T1w scans. Four MR-HIFU radiologists assessed the outcome of MR-HIFU treatments and NPV ratio based on the synthetic and reference CE-T1w scans.

RESULTS: Dice coefficient of NPVs was 71% (± 22%). The mean difference in NPV ratio was 1.4% (± 22%) and not statistically significant (p = 0.79). Absolute agreement of the radiologists on technical treatment success on synthetic and reference CE-T1w scans was 83%. NPV ratio estimations on synthetic and reference CE-T1w scans were not significantly different (p = 0.27).

CONCLUSIONS: Deep learning-based synthetic CE-T1w scans derived from intraprocedural DWI allow gadolinium-free visualization of the predicted NPV, and can potentially be used for repeated gadolinium-free monitoring of treatment progression during MR-HIFU therapy for uterine fibroids.

KEY POINTS: • Synthetic CE-T1w scans can be derived from diffusion-weighted imaging using deep learning. • Synthetic CE-T1w scans may be used for visualization of the NPV without using a contrast agent directly after MR-HIFU ablations of uterine fibroids.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Slotman, Bartels, Zijlstra, et al. Diffusion-weighted MRI with deep learning for visualizing treatment results of MR-guided HIFU ablation of uterine fibroids. Eur Radiol. 2022. PMID: 36472702. doi:10.1007/s00330-022-09294-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。